Clinical trial
A Randomized, Phase III, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Palifermin (NSC# 740548; IND # 6370) for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Radiation Therapy With Concurrent Chemotherapy (Followed by Surgery for Selected Patients)
NCT00360971 is registered in ClinicalTrials.gov with Radiation Therapy Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Phase III, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Palifermin (NSC# 740548; IND # 6370) for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Radiation Therapy With Concurrent Chemotherapy (Followed by Surgery for Selected Patients)
- Lead sponsor
- Radiation Therapy Oncology Group
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- July 31, 2006
- Completion date
- February 28, 2009
- Enrollment
- 21 (actual)
- Sites
- 48
Conditions
As the registry lists them; a condition with its own page is linked.